[embed_youtube”420″ height=”315″ src=”http://www.youtube.com/embed/ViLYG9bVnmI”]
Search Results for:
Avastin Carries Higher Risk for Blindness for Macular Degeneration Treatments
Lucentis and Avastin are both used to treat the wet version of age-related macular degeneration. A new study from Queen’s University finds that Avastin, traditionally a cancer drug, carries a much higher risk for the development of serious intraocular inflammation, which can lead to blindness. A review of 1,600 cases...